Neoadjuvante Chemotherapie des Mammakarzinoms

[1]  Min-Ying Su,et al.  Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRI , 2003, Breast Cancer Research and Treatment.

[2]  Daniele Regge,et al.  Monitoring Response to Primary Chemotherapy in Breast Cancer using Dynamic Contrast-enhanced Magnetic Resonance Imaging , 2004, Breast Cancer Research and Treatment.

[3]  M. Dewhirst,et al.  Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. , 2003, AJR. American journal of roentgenology.

[4]  C. Balu-Maestro,et al.  Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. , 2005, Breast cancer research and treatment.

[5]  H. Junkermann,et al.  Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy , 2003, European Radiology.

[6]  Ying Lu,et al.  Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. , 2002, AJR. American journal of roentgenology.

[7]  H. Koyama,et al.  [The role of neoadjuvant chemotherapy for breast cancer treatment]. , 2002, Gan to kagaku ryoho. Cancer & chemotherapy.

[8]  I. Zuna,et al.  Evaluation of neoadjuvant chemotherapeutic response of breast cancer using dynamic MRI with high temporal resolution , 2002, European Radiology.

[9]  G. Gasparini,et al.  Metronomic scheduling: the future of chemotherapy? , 2001, The Lancet. Oncology.

[10]  P J Drew,et al.  Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. , 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[11]  G. van Kaick,et al.  Nichtinvasive Untersuchung der Mikrozirkulation von neoplastischen Erkrankungen , 2001, Der Onkologe.

[12]  G J Metzger,et al.  MRI vs. histologic measurement of breast cancer following chemotherapy: Comparison with x‐ray mammography and palpation , 2001, Journal of magnetic resonance imaging : JMRI.

[13]  G Brix,et al.  Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.

[14]  M V Knopp,et al.  Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  I. Zuna,et al.  Multi-reader-analysis to assess functional MR-Mammography , 1998, Der Radiologe.

[16]  H. Junkermann,et al.  Imaging procedures for assessment of the response of mammary carcinoma to preoperative chemotherapy , 1997, Der Radiologe.

[17]  G. Brix,et al.  Methods for quantitative assessment of tissue microcirculation using dynamic contrast-enhanced MR imaging , 1997, Der Radiologe.

[18]  H Zeitler,et al.  MRI of breast cancer: influence of chemotherapy on sensitivity. , 1997, The British journal of radiology.

[19]  P. V. van Diest,et al.  Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. , 1997, American journal of clinical pathology.

[20]  C. Claussen,et al.  Dynamic 3d‐mr mammography: Is there a benefit of sophisticated evaluation of enhancement curves for clinical routine? , 1997, Journal of magnetic resonance imaging : JMRI.

[21]  G Brix,et al.  [Fast MRI contrast medium dynamics for characterization of tumors. Experiences with functional MR-mammography]. , 1995, Der Radiologe.

[22]  W. J. Lorenz,et al.  Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.

[23]  G Brix,et al.  MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. , 1994, Magnetic resonance imaging clinics of North America.

[24]  M. Kaufmann,et al.  Histologische Regression des Mammakarzinoms nach primärer (neoadjuvanter) Chemotherapie , 1994 .

[25]  H. Junkermann,et al.  Pharmakokinetische Analyse der Gd-DTPA-Anreicherung in der MRT beim Mammakarzinom , 1994 .

[26]  G van Kaick,et al.  [Echomorphology of breast cancer]. , 1993, Der Radiologe.

[27]  S. Schnitt,et al.  Evaluation of breast biopsy specimens in patients considered for treatment by conservative surgery and radiation therapy for early breast cancer. , 1988, Pathology annual.